Impact of the 13-valent conjugate pneumococcal vaccine on the incidence of invasive pneumococcal disease in Catalonia: Retrospective study, 2014¿2015 vs. 2017¿2018 S. Broner; C. Izquierdo; M.M. Nogueras; S. Hernández; C. Muñoz-Almagro; R. Pallarés; M. Jané; P. Ciruela;

Does the change in the immunization dosing schedule of 10-valent pneumococcal conjugate vaccine has any impact among children in the northwest of Sao Paulo, Brazil? R.P.-D.l. Ossa; R.G. Sieben; M.C. Cervi; D.A.F.d.S. Lima; R. Santos; D.C. Aragon;

Nasopharyngeal carriage, serotype pattern and antimicrobial non-susceptibilities of Streptococcus pneumoniae among healthy children in the 13-valent pneumococcal conjugate vaccine era in Barbados, one of the Caribbean countries Alok Kumar; Kandamaran Krishnamurthy; Euclid Morris; Marquita Gittens-St. Hilair;